A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon γ and human recombinant interferon α2B therapy in patients with metastatic renal cell carcinoma: Clinical outcome and analysis of immunological parameters

Journal of Urology

Volumn 163, Issue 4, 2000, Pages 1322-1327

  Schwaab, Thomas ^a   Heaney, John A ^a   Schned, Alan R ^a   Harris, Robert D ^a   Cole, Bernard F ^a   Noelle, Randolph J ^a   Phillips, Dorothy M ^a   Stempkowski, Laura ^a   Ernstoff, Marc S ^a  

^a NORRIS COTTON CANCER CENTER   (United States)

Author keywords

Autologous vaccine; Immune regulation; Interferon; Renal cell cancer

Indexed keywords

CANCER VACCINE; CYTOKINE; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GAMMA INTERFERON; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; IMMUNOMODULATION; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; OUTCOMES RESEARCH; PHASE 2 CLINICAL TRIAL; PHENOTYPE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0034068534     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)67771-3     Document Type: Article

References (24)

1. Mulders, P., Figlin, R., deKernion, J. B., Wiltrout, R., Linehan, M., Parkinson, D., deWolf, W. and Belldegrun, A.: Renal cell carcinoma: recent progress and future directions. Cancer Res, 57: 5189, 1997
2. Concolino, G., Marocchi, A., Condo, C., Tenaglia, R., DiSilverio, F. and Bracci, U.: Human renal cell carcinoma as a hormone-dependent tumor. Cancer Res, 38: 4340, 1978
3. Debruyne, F. M. J., Franssen, M. P. H., Beniers, A. J. M. C., Schalken, J. A. and deMulder, P. M. H.: New prospects in the management of metastatic renal cell carcinoma. Experimental and clinical data. Uro-Oncology: Current Status and Future Trends, 243, 1990
4. Ernstoff, M. S., Nair, S., Bahnson, R. R., Miketic, L. M., Banner, B., Gooding, W., Day, R., Whiteside, T., Hakala, T. and Kirkwood, J. M.: A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alpha in patients with metastatic renal cell carcinoma. J Clin Oncol, 8: 1637, 1990
5. Rosenberg, S. A., Lotze, M. T., Moul, J., Chang, A. E., Avis, F. P., Leitmann, S., Linehan, W. M., Robertson, C. N., Lee, R. E., Rubin, J. T., Seipp, C. A., Simpson, C. G. and White, D. Z.: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. New Engl J Med, 316: 879, 1987
6. Wagstaff, J. and Melief, K. J.: In: Cancer Chemotherapy and Biological Response Modifiers. Edited by Pinedo, H. M., Lomgo, D. L. and, Chabner, B. A. Annual 9, Amsterdam: Elseviers Science Publishers BV, pp 432, 1987
7. Lubeck, M. D., Steplewski, Z., Baglia, F., Klein, M. H., Dorrington, K. J. and Koprowski, H.: The interaction of murine IgG subclass proteins with human monocyte Fc receptors. J Immunol, 135: 1299, 1985
8. Doveil, G. C., Fierno, M. T., Novelli, M., Appino, A., Bertero, M., Quaglino, P. and Bernengo, M. G.: Adjuvant therapy of stage IIIb melanoma with interferon alpha-2b: Clinical and immunological relevance. Dermatology, 191: 234, 1995
9. Krown, S. E.: Interferon treatment of renal cell carcinoma. Current status and future prospects. Cancer, 46: 4315, 1986
10. Gohji, K., Fidler, I. J., Tsan, R., Radinsky, R., von Eschenbach, A. C., Tsuruo, T. and Nakajima, M.: Human recombinant interferons-beta and-gamma decrease gelatinase production and invasion by human KG-2 renal cell carcinoma cells. Int J Cancer, 58: 380, 1994
11. Ernstoff, M. S., Gooding, W., Nair, S., Bahnson, R. P., Miketic, L. M., Banner, B., Day, R., Whiteside, T., Titus-Ernstoff, L. and Kirkwood, J. M.: Immunological effects of treatment with sequential administration of recombinant IFN χ and α in patients with metastatic renal cell carcinoma during a phase I trial. Cancer Res, 52: 851, 1992
12. DeKernion, J. B., Sarna, G., Figlin, A. and Smith, R. B.: The treatment of renal cell carcinoma with human leukocyte alpha-interferon. J Urol, 130: 1063, 1983
13. Otto, U., Schneider, A. W., Conrad, S. and Klosterhalfen, H.: Recombinant alpha-2 or gamma interferon in the treatment of metastatic renal cell carcinoma: results of two phase II/III trials. Uro-Oncology: Current Status and Future Trends, 275, 1990
14. Repmann, R., Wagner, S. and Richter, A.: Adjuvant therapy of renal cell carcinoma with active-specific-immunotherapy (ASI) using autologous tumor vaccine. Anticancer Res, 17: 2879, 1997
15. McCune, C. S., Schapira, D. V. and Henshaw, E.G.: Specific immunotherapy for advanced renal cell carcinoma: evidence for the polyclonality of metastases. Cancer, 47: 1984, 1981
16. Kim, T-Y., von Eschenbach, A. C., Filaccio, M. D., Hayakawa, K., Parkinson, D. .R. and Balch, C. M.: Clonal analysis of lymphocytes from tumor, peripheral blood, and nontumorous kidney in primary renal cell carcinoma. Cancer Res, 50: 2363, 1990
17. Koo, A. S., Tso, C. L., Shimabukuro, T., Peyret, C., Dekernion, J. B. and Belldegrun, A.: Autologous tumor-specific cytotoxicity of tumor-infiltrating lymphocytes derived from human renal cell carcinoma. J Immunother, 10: 347, 1991
18. Brouwenstijn, N., Gaugler, B., Kruse, K. M., ven der Spek, C. W., Mulder, A., Osanto, S., van den Eynde, B. J. and Schrier, P.: Renal cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes. Int J Cancer, 68: 177, 1996
19. Schendel, D. J., Gansbacher, B., Oberneder, R., Kriegmair, M., Hofstetter, A., Riethmuller, G. and Seguardo, O. G.: Tumorsspecific lysis of human renal cell carcinomas by tumor-infiltrting lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines. J Immunol, 151: 4209, 1993
20. Sayers, T. J., Wiltrout, T. A., McCormick, K., Husted, C. and Wiltrout, R. H.: Antitumor effects of α-interferon on a murine renal cancer (Renca) in vitro and in vivo. Cancer Res, 50: 5414, 1990
21. Gorsch, S., Ernstoff, M. S., Heaney, J. A. and Peschel, R. F.: Urologic Cancer. Blackwell Sciences, 1997
22. McCune, C. S., O'Donnel, R. W., Marquis, D. M. and Sahasrabudhe, D. M.: Renal cell carcinoma treated by vaccines fo active specific immunotherapy: correlation of survival with skin testing by autologous tumor cells. Cancer Immunol Immunother, 32: 62, 1990
23. Galligioni, E., Quaia, M., Merlo, A., Carbone, A., Spada, A., Favaro, D., Santarosa, M., Sacco, C. and Talamini, R.: Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guerin. Cancer, 77: 2560, 1996
24. Matjissen, V., Van Moorselaar, J., DeMulder, P. H., Schalkwijk, L. and Ruiter, D. J.: Human leukocyte antigen expression in renal cell carcinoma lesions does not predict the response to interferon therapy. J Immunother, 12: 64, 1992